Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis.
Lederer DJ, Bradford WZ, Fagan EA, Glaspole I, Glassberg MK, Glasscock KF, Kardatzke D, King TE Jr, Lancaster LH, Nathan SD, Pereira CA, Sahn SA, Swigris JJ, Noble PW.
Lederer DJ, et al. Among authors: glassberg mk.
Chest. 2015 Jul;148(1):196-201. doi: 10.1378/chest.14-2817.
Chest. 2015.
PMID: 25856121
Free PMC article.
Clinical Trial.